By Ransdell Pierson
July 12 (Reuters) - Despite two failed late-stage trials of
its experimental Alzheimer's drug solanezumab, Eli Lilly and Co
Read Whole Story
Researchers have chosen an experimental drug by Eli Lilly & Co. for a large federally funded study testing whether it's possible to prevent Alzheimer'...
Get top stories and blog posts emailed to me each day. Newsletters may offer personalized content or advertisements. Learn more.